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(B) H&E stained sagittal paraffin sections of ALK fish (top left panesl). Boxes indicate the SCG and IRG, and are magnified in the right panels respectively (top right panels). H&E stained, sagittal paraffin sections of MYCN;ALK compound transgenic fish (lower left panels). Boxed region shows a tumor in the IRG, with magnified views in the lower right panels. G, gill; L, liver. Scale bars, 50 m.
(C) Immunohistochemical analysis of different neuroblastoma markers on sagittal sections through the IRG of the ALK transgenic fish (top panels) and through a tumor in the MYCN;ALK compound transgenic fish (lower panels). Tyrosine hydroxylase (TH) (left panels), Synatophysin (Synap) (middle panels) and Hu (right panels) expression. Scale bar, 100 m. Neuroblastomas were not identified in the MYCN fish coinjected with dβh-ALKWT and dβh-mCherry or dβh-mCherry alone at 7 wpf, or in any of the siblings that did not inherit the MYCN transgene and were injected with either the ALKWT gene or the ALKF1174L gene. To determine whether the presence or absence of EGFP+ sympathoadrenal cells in the region of the superior cervical ganglia (SCG) of MYCN-expressing fish affects tumor onset, heterozygous MYCN and ALK transgenic fish were crossed and the offspring were sorted at 5 dpf based on the presence of EGFP+ cells (SCG+ MYCN+ and SCG-MYCN+). These embryos were raised and monitored for the onset of tumorigenesis as described in the Methods. By 11 wpf, no significant differences in tumor formation were detected in MYCN transgenic fish or MYCN;ALK compound transgenic fish with respect to the presence or absence of EGFP+ cells in the SCG at 5 dpf. The ratio of SCG+ to SCG-embryos at 5dpf was 1:4, but was reduced to 1:2 by 11 wpf. It is likely that the lack of sympathoadrenal cells in the SCG-group affects animals with relatively more severe defects in the PSNS development, leading to more death in the SCG-group over time. (A) Transverse sections through the spinal cord (sc) of wild-type fish stained for apoptosis using the TUNEL assay. TUNEL-positive cells were not detected in the fish without irradiation (top panels), but were observed in the fish irradiated (at 12.5 Gy) at 28 hpf (red in lower panels), which serves as a controls for TUNEL assay. IR, irradiated.
(B) Transverse sections through the spinal cord of DβH (top panels) and MYCN (lower panels) transgenic animals stained for TUNEL at 51 hpf. TUNEL-positive EGFP+ sympathoadrenal (SA) cells of the DβH transgenic embryo was rarely observed. In MYCN transgenic embryos, EGFP+ SA cells were scarce, and TUNEL+ cells were not observed in the SA cells. Arrows point to the EGFP+ sympathoadrenal (SA) cells. 
Supplemental Experimental Procedures:
Zebrafish: Embryos were staged according to Kimmel et al. (Kimmel et al., 1995) . All zebrafish studies and maintenance of the animals were in accord with Dana-Farber Cancer Institute IACUC-approved protocol #02-107.
DNA constructs for transgenesis:
A 5.2-kb dβh promoter region was cloned using the CH211-270H11 BAC as a DNA template and the Expand Long Template PCR System (Roche Applied Science, IN), with the following cycle times: 94C, 2 min, 10 cycles of (94C, 15 sec, 50C, 30 sec, 68C, 8 min), followed by 30 cycles of (94C, 15 sec, 53C, 30 sec, 68C, 8 min), 68C, 4 min (forward primer 5'-GCG TAC TCC CCC TTT TTA GG-3' and reverse primer 5'-TGT TGC TTT GTC GTC TTT TGA-3'). The PCR product was first cloned into a pCR-TOPO vector (Invitrogen, CA), subcloned into XhoI-ClaI restriction sites of a I-SceI-pBSII-SK+ vector (GI:111054490, a generous gift from Dr. C. Grabher, Karlsruhe Institute of Technology, Karlsruhe, Germany) and injected into one-cell embryos to generate the Tg(dβh:EGFP) transgenic line. The expression of EGFP in the Tg(dβh:EGFP) zebrafish line recapitulated endogenous expression of dβh and is designated the "DβH" transgenic line in the main body of the text. The DNA construct for the Tg(dβh:EGFP-MYCN) transgenic line was made using the Multisite Gateway System (Invitrogen, CA), by combining entry clones of the 5.2-kb dβh promoter and EGFP lacking a stop codon, and human MYCN cDNA (a generous gift from Dr. Hogarty at the Children's Hospital of Pennsylvania) into the modified destination vector containing I-SceI recognition sites. The PNP-mitf vector (a generous gift from Dr. D. Raible, Univ. of Washington) was used to release a 2.65-kb DNA fragment from NotI and SalI restriction sites, containing the promoter and the coding sequence of the zebrafish mitf gene, which was cloned into the MluI and NotI sites of a modified pBluescript vector containing flanking I-SceI recognition sites. To generate transgenic animals overexpressing MYCN under control of the dβh promoter, dβh:EGFP-MYCN and mitf:mitf DNA constructs were coinjected with fresh I-SceI enzyme into embryos of the pigmentation mutant nacre zebrafish at the one-cell stage, and the injected embryos were grown to adulthood. The adult fish were incrossed to identify stable transgenic animals based on pigmentation and EGFP expression; once identified, the lines were maintained and expanded by outcrossing into the wild-type AB strain. The mitf promoter is specific for cells of the melanocyte lineage and is not expressed in the sympathoadrenal cells. The Tg(dβh:EGFP-MYCN) line is designated the "MYCN" transgenic line in the main body of the text.
To generate the Tg(dβh:EGFP;dβh:ALKF1174L) transgenic line, we subcloned the human ALKF1174L gene from the PCDNA3 vector (George et al., 2008) into EcoRI and NotI sites of a pENTRY1A vector and constructed the expression clone by combining three entry clones, dβh-pDONRP4-P1R, ALKF1174L-pENTRY1A and p3E-polyA, with a pDest I-SceI destination vector using the multisite Gateway system. To generate a stable line, we linearized this dβh:ALKF1174L DNA construct and the dβh:EGFP DNA constructs (3:1 ratio), used to create the DβH line, with the I-SceI enzyme. 50-80 pg of total DNA was then injected into one-cell stage wild-type embryos. The Tg(dβh:EGFP;dβh:ALKF1174L) zebrafish line is designated the "ALK" transgenic line in the main body of text. F1 offspring were first screened by fluorescent microscopy for EGFP expression, and the germline transmission of the ALK (F1174L) gene was confirmed by genomic PCR of the EGFP-positive embryos with the following primers: ALK P7: 5'-AGG CCA GGT GTC CGG AAT GC-3' and ALK P18: 5'-TGT CTT CAG GCT GAT GTT GC-3' and the following PCR reaction: 1 cycle of 94°C for 5 min, 30 cycles of (94°C for 30 s, 55°C for 30 s, and 72°C for 60 s). A 721-bp fragment of the ALK transgene fragment containing the F1174L mutation was amplified and confirmed by sequencing.
Tumor watch and genotyping of transgenic fish: MYCN and ALK heterozygous transgenic fish were crossed and the offspring were grown under identical conditions. The zebrafish line carrying both MYCN and ALK transgenes is designated the "MYCN;ALK" transgenic line in the main body of text. Starting at 5 weeks postfertilization, offspring were anesthetized with tricaine and examined every two weeks for EGFP-expressing tumor masses. Once fish with strong EGFP-positive tumors were identified, they were genotyped, fixed, sectioned, and stained with H&E. All of the screened fish were genotyped at 6 months of age to provide data for determining tumor incidence over time. For genotyping, genomic DNA extracted from finclip was PCRamplified with the following primers: ALK P9: 5'-GAA ACA AGC CCA CCA GCT TG-3'; ALK P20: 5'-CCA GGC TGG TTC ATG CTA TT-3'; MYCN-test F1: 5'-CTG CTT GAG AAC GAG CTG TG-3'; MYCN-R3: 5'-AGG CAT CGT TTG AGG ATC AG-3'. ALK genotyping PCR was performed with Taq DNA Polymerase (New England Biolabs, MA) using the program described above, while MYCN genotyping was performed with the GC-RICH PCR System (Roche Applied Science, IN) using the following program: 1 cycle of 95°C for 3 min, 25 cycles of 95°C for 30 s, 58°C for 30 s, and 72°C for 3 min.
In addition, for Figure 3B , either activated human ALK(F1174L) or wild-type human ALK (ALKWT) were overexpressed in the MYCN fish as mosaics by coinjecting the following constructs into the one-cell stage of MYCN transgenic and control embryos: i) dβh-ALKF1174L with dβh-mCherry, ii) dβh-ALKWT with dβh-mCherry or iii) dβh-mCherry alone. The primary injected embryos were raised and monitored for the onset of tumorigenesis, as described above.
Semiquantitative and quantitative RT-PCR:
To detect the ALK transgene expression, we extracted total RNA from tumors dissected from individual MYCN;ALK and MYCN only transgenic fish using TRIZOL (Invitrogen, CA) and treated RNA with TURBO™ DNase (Applied Biosystems, CA). CDNA was produced using the SuperScript® III First-Strand Synthesis System for RT-PCR (Invitrogen, CA). For controls, no reverse transcriptase was added to the same mRNA samples. ALK was amplified using ALK P9 and P20 primers for 32 cycles, while β-actin was amplified as a loading control using primers (actin F2: 5'-AAT CCC AAA GCC AAC AGA GA-3'; actin R2: 5'-TCA CAC CAT CAC CAG AGT CC-3') for 25 cycles. To assess the expression of zebrafish endogenous caspase-8 expression, total RNA was extracted from EGFP-positive tumor cells sorted from three individual MYCN tumor and pooled EGFP-expressing cells sorted from DβH control fish. The quantitative PCR was carried on ViiA™ 7 real-time PCR machine (Life Technologies Corporation, CA) using primers for amplification of caspase-8 (z-casp8-F 5´-GGGCAAAGCTGGGAAGATC-3´; z-casp8-R 5´-CTTCTTCTAGAGGAAGTCTGC-3´) and β-actin (see above).
RNA in situ hybridization: Whole-mount RNA in situ hybridization assays were performed according to Thisse and Thisse (Thisse and Thisse, 2008) . DNA of dβh, th, phox2b and tfap2a for making RNA probes have been described (Stewart et al., 2006) .
Cryosectioning, paraffin sectioning and immunostaining: For cryosectioning, embryos or juvenile fish at indicated stages were fixed with 4% paraformaldehyde at 4C overnight, washed with phosphate-buffered saline with 0.1% Tween 20 (PBST), embedded in 1.5% agar / 5% sucrose, and sunk in 30% sucrose at 4C overnight. 14-m sections were taken from the embedded specimens with a conventional cryostat. For immunofluorescence assays, primary antibodies against EGFP (Invitrogen, Cat# A6455, 1:500), TH (Pel-Freez, Cat# P40101, 1:500), HuC/D (Invitrogen, Cat# A-21271, 1:200) , Synaptophysin (Millipore, Cat# MAB5258, 1:200) , ALK/p80 antibody (Epitomics, Cat# 4204-1, 1:100) and activated Caspase-3 (BD Biosciences, Cat#559565, 1:250) were incubated on slides at 4C overnight, washed with PBST, visualized with secondary antibodies conjugated with Alexa 488, 568, 647 (Invitrogen, 1:500), and counterstained with DAPI for nuclear staining.
Paraffin sectioning followed by H&E staining and immunohistochemistry was performed at the DF/HCC Research Pathology Core with primary antibodies against GFP, TH, HuC/D, Synaptophysin and ALK/p80 antibody using standard protocols (Macdonald, 1999) .
Electron microscopy: Transmission electron microscopy (TEM) was carried out at the Harvard Medical School EM Facility. Briefly, the dissected tumor tissues were fixed in 2% formaldehyde/2.5% glutaraldehyde, postfixed with 1% osmiumtetroxide, and embedded in epon; 80-nm sections were then collected. Images were captured by a Tecnai™ G² Spirit BioTWIN electron microscope with an AMT 2k CCD camera.
Imaging: An Olympus stereoscopic microscope and a Leica M420 microscope equipped with a Nikon digital sight DS-U1 camera were used for capturing the bright field and fluorescent images. A Zeiss LSM 510 META confocal microscope at the Harvard Neurodiscovery Imaging Center and a Leica SP5X laser scanning confocal microscope at the Confocal and Light Microscopy core facility at Dana-Farber Cancer Institute were used for collecting confocal images of the native EGFP and antibody staining. Images of optical sections (3-5 μm each) acquired with a 20X water immersion lens (N. A. = 0.7), were taken of whole-mounted embryos, while 40X/63X/100X oil immersion lenses (N. A. = 1.4) were used for viewing sections. For brightfield DIC images, a Zeiss Axio Imager.Z1 compound microscope equipped with an AxioCam HRc was used. The acquired images were processed and compiled with Leica LAS AF Lite, Openlab v5 (Improvision) and Adobe Photoshop and Illustrator CS3 (Adobe) software.
Cell counts:
To identify the cells that give rise to neuroblastoma, the DβH, ALK, MYCN and MYCN;ALK transgenic fish at 3 wpf, 5 wpf, 5.5 wpf and 7 wpf were cryosectioned, stained with primary antibodies against HuC/D, GFP, TH and activated Caspase-3, and imaged using confocal microscopy. All sections from each individual fish were scanned for three types of cells: i) neuroblast cells that were Hu-positive, ii) chromaffin cells that were Hu-negative/GFP-positive, and iii) apoptotic neuroblast cells that were coexpressed activated Caspase-3-positive and Hu. For each cell type/condition a single representative section was selected that contained the largest number of each respective cell type and the numbers of those cells were quantified.
Statistical analysis: Kaplan-Meier analysis was applied to assess the rate of tumor development. Fish that died prior to evidence of external EGFP-positive masses were censored. When tissue from the dead fish was available, the genotype was determined; otherwise, genotypes for the fish that were lost or died were based on the following assumptions. The offspring from the cross of MYCN and ALK heterozygous stable transgenic fish contain each of the four genotypes in equal proportions. However, based on the genotypes of available fish, MYCN+ fish died during development more often than MYCN-fish. Thus, the fish that could not be genotyped were likely to have the MYCN+ genotype and were designated as such for this study. Since roughly equal numbers of ALK+ and ALK-fish were observed among both the MYCN-and MYCN+ groups, the total number of dead, but ungenotyped, fish was divided equally between the Alk+ and Alk-cohorts within the MYCN+ group. The Fisher exact test was used to assess the difference between tumor onset by 9 wpf in the MYCN fish coinjected with dβh-ALKF1174L and dβh-mCherry and that in the MYCN line coinjected with dβh-ALKwt and dβh-mCherry or dβh-mCherry alone. The Wilcoxon signed-rank test was used to assess the difference between the numbers of Hu-positive neurons or Hu-negative/GFP-positive chromaffin cells in the DβH, ALK, MYCN and MYCN;ALK transgenic fish at 3 wpf, 5wpf, 5.5 wpf and 7 wpf. The numbers of MYCN transgenic fish with Hu-positive apoptotic cells were compared to those of DβH, ALK and MYCN;ALK transgenic fish at 5.5 wpf using Fisher exact test. The Fisher exact test was used to assess the difference between tumor onset by 11 wpf in the MYCN transgenic fish with residual superior cervical ganglia cells (SCG+) and that in the MYCN transgenic fish lacked superior cervical ganglia cells (SCG-) at 5 dpf.
